1. Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysis. Issue 1 (25th November 2018) Authors: Kutlar, Abdullah; Kanter, Julie; Liles, Darla K.; Alvarez, Ofelia A.; Cançado, Rodolfo D.; Friedrisch, João R.; Knight‐Madden, Jennifer M.; Bruederle, Andreas; Shi, Michael; Zhu, Zewen; Ataga, Kenneth I. Journal: American journal of hematology Issue: Volume 94:Issue 1(2019:Jan.) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Influence of Gestational Age at Initiation of Antihypertensive Therapy: Secondary Analysis of CHIPS Trial Data (Control of Hypertension in Pregnancy Study). Issue 6 (June 2018) Authors: Pels, Anouk; Mol, Ben Willem J.; Singer, Joel; Lee, Terry; von Dadelszen, Peter; Ganzevoort, Wessel; Asztalos, Elizabeth; Magee, Laura A.; Gafni, Amiram; Gruslin, Andrée; Helewa, Michael; Hutton, Eileen; Lee, Shoo; Logan, Alexander; Menzies, Jennifer; Moutquin, Jean-Marie; Murphy, Kellie; Rey, Ev... Journal: Hypertension Issue: Volume 71:Issue 6(2018:Jun.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation. (22nd January 2015) Authors: Scheid, Christof; Reece, Donna; Beksac, Meral; Spencer, Andrew; Callander, Natalie; Sonneveld, Pieter; Kalimi, Ghulam; Cai, Can; Shi, Michael; Scott, Jeffrey W.; Stewart, A. Keith Journal: European journal of haematology Issue: Volume 95:Number 4(2015:Oct.) Page Start: 316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2− breast cancer that had progressed during or after prior endocrine therapy. Issue 1 (December 2017) Authors: Musolino, Antonino; Campone, Mario; Neven, Patrick; Denduluri, Neelima; Barrios, Carlos; Cortes, Javier; Blackwell, Kimberly; Soliman, Hatem; Kahan, Zsuzsanna; Bonnefoi, Hervé; Squires, Matthew; Zhang, Yong; Deudon, Stephanie; Shi, Michael; André, Fabrice Journal: Breast cancer research Issue: Volume 19:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients. (December 2007) Authors: Azuma, Mizutomo; Shi, Michael; Danenberg, Kathleen D; Gardner, Humphrey; Barrett, Carl; Jacques, Christian J; Sherod, Andrew; Iqbal, Syma; El-Khoueiry, Anthony; Yang, Dongyun; Zhang, Wu; Danenberg, Peter V; Lenz, Heinz-Josef Journal: Pharmacogenomics Issue: Volume 8:Number 12(2007) Page Start: 1705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Xeno‐Free Reprogramming of Peripheral Blood Mononuclear Erythroblasts on Laminin‐521. (24th January 2020) Authors: Skorik, Christian; Mullin, Nathaniel K.; Shi, Michael; Zhang, Yosra; Hunter, Phoebe; Tang, Yang; Hilton, Brianna; Schlaeger, Thorsten M. Editors: Bhatia, Mick; Elefanty, Andrew G.; Fisher, Susan J.; Patient, Roger; Schlaeger, Thorsten; Snyder, Evan Y. Journal: Current protocols in stem cell biology Issue: Volume 52(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗